SNX9-AS1

Across TCGA pan-cancer cohorts, SNX9-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated SNX9-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SNX9-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX9-AS1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and THYM show a favorable association.

ACC, BRCA, and LIHC are the cancer types where SNX9-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	II,III,IV	0.404	0.877	<.001	93	view →
BRCA	DFS	Tertile	III,IV	0.956	0.850	.004	41	view →
LIHC	DFS	Tertile	III,IV	0.100	0.347	<.001	39	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	27	view →
UCEC	DFS	Tertile	All	0.478	0.678	.010	18	view →
OV	OS	Median	IV	0.258	0.500	.002	12	view →
SKCM	OS	Tertile	IV	0.133	0.621	.019	9	view →
THYM	OS	Median	All	1.000	0.680	.011	9	view →
THCA	DFS	Tertile	IV	0.572	0.874	.016	9	view →
LUSC	OS	Tertile	III,IV	0.171	0.601	.049	9	view →
HNSC	DFS	Tertile	II,III,IV	0.572	0.317	.031	9	view →
STAD	DFS	Median	IV	0.322	0.622	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

SNX9-AS1–ACC (OS)

Open the ACC breakdown →